Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Minocycline for Central Retinal Vein Occlusion
2017-001143-12Phase 2Unknown
- Sponsor
- National Eye Institute
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in central retinal vein occlusion (CRVO) comparing Minocycline arm with Placebo arm (2 arms). Primary endpoint: Change in best-corrected visual acuity at 12 months. Status: unknown.
02
Drugs
minocycline
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on 2017-001143-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001143-12.